The discovery of glycine as co-agonist at the NMDA receptor complex (NRC) by Johnson & Ascher (1987, Nature 325: 529) is one of the most perplexing highlights of neuroscience research. As another surprise Hashimoto et al. found out that D-serine makes up for about 1/3 of the mammalian brain's serine (1993, J. Neurochem. 60: 783); this quite unusual amino acid acts at the glycine site of the NRC as potently as glycine itself. In cooperation with Christian Noe (Pharmaceutical Chemistry, University Vienna) and the Pharmaceutical Company E. Merck (Darmstadt) many new compounds were synthesized and tested at this binding site.